ZIM Laboratories Limited
NSE ZIMLAB.NS
ZIM Laboratories Limited Free Cash Flow Per Share for the year ending March 31, 2024: USD -0.14
-
ZIM Laboratories Limited Free Cash Flow Per Share for the year ending March 31, 2023 was USD 0.00, a -97.68% change year over year.
-
ZIM Laboratories Limited Free Cash Flow Per Share for the year ending March 31, 2022 was USD 0.09, a 29.03% change year over year.
-
ZIM Laboratories Limited Free Cash Flow Per Share for the year ending March 31, 2021 was USD 0.07, a 668.33% change year over year.
-
ZIM Laboratories Limited Free Cash Flow Per Share for the year ending March 31, 2020 was USD 0.01, a -78.52% change year over year.
| Date | Free Cash Flow Per Share | Return on Assets (ROA) | Return on Equity (ROE) | Return on Capital Employed (ROCE) |
|---|
Don’t Miss A Beat
| CEO | Dr. Chandrashekhar Mainde |
| IPO Date | Nov. 25, 2022 |
| Location | India |
| Headquarters | Sadoday Gyan |
| Employees | 556 |
| Sector | Healthcare |
| Industries | |
ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally. The company provides technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for generic pharmaceutical products in semi-finished and finished categories/formulations, such as granules, pellets, taste masked powders, suspensions, tablets, capsules, and oral thin films. It serves therapeutic areas, such as urology, gastroenterology, cardiology, and anticoagulants, as well as antibiotics and anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.
Past 5 years
USD 11.04
USD 9.83
USD 10.98
USD 130.56
USD 13.56
StockViz Staff
February 12, 2025
Any question? Send us an email